Phase 3 trial of new malaria vaccine reveals promising results in protecting children
The Lancet published peer-reviewed results from a Phase 3 efficacy trial of the R21/Matrix-M™ malaria vaccine. The World Health Organization recently prequalified the vaccine, leading to a global rollout expected…
My Life With This Skin Condition
Mark Braxton discovered he had vitiligo in 1996 when he noticed white spots on his skin. The condition affected his self-esteem and made him feel insecure and isolated. He tried…
A Good Alternative for Adolescent Scoliosis
A new trial, led by Anastasios Charalampidis, MD, PhD, with the Department of Clinical Science, used self-managed physical activity combined with either nighttime bracing for 8 hours or scoliosis-specific exercise…
Know Signs, Risk Factors Of Deadly Fungal Infection
Candida auris, a deadly fungal infection that is on the rise in the U.S., has been reported for the first time in Washington state. It can cause severe illness in…
Both psychotherapy and antidepressants feasible options for managing depression in HF patients: JAMA
A study published in the Journal of the American Medical Association (JAMA) found that both psychotherapy and antidepressants are viable options for managing depression in patients with heart failure. The…
Quiet Neglect: Algorithmic Bias in Healthcare Is Hurting Older Adults
AI algorithms have the potential to improve health monitoring for older adults, but data gaps risk widening health inequities. Healthcare algorithms are largely built from data that exclude older adults,…
Extracranial Surgery, Anesthesia After TBI Tied to Poorer Clinical Outcomes
A study published in JAMA Surgery found that extracranial surgery and anesthesia are linked to worsened cognitive and functional outcomes after traumatic brain injury (TBI). The study, based on data…
Possibility of Wildlife-to-Human Crossover Heightens Concern About Chronic Wasting Disease
Chronic Wasting Disease (CWD) is spreading among deer populations and has the potential to infect humans. Research shows that the barriers to spillover into humans are less formidable than previously…
The lessons of Aduhelm, an Alzheimer’s drug that was not to be
Biogen announced that it would no longer sell or study Aduhelm, an Alzheimer's disease treatment that was approved in 2021, due to corporate mistakes and regulatory issues. This marks the…
Peer review of funding applications for health research in ethnic minority groups must improve
Laura Kudrna and her colleagues argue that for better health outcomes for ethnic minority groups, higher quality and more inclusive health research is necessary. They discuss the current limitations in…